Answers are grounded in this paper and cite their sources.
Methodological review outlines therapeutic strategies for radical cure in vivax malaria, highlighting challenges in evaluating hypnozoitocidal drug regimens.
The radical cure for Plasmodium vivax malaria involves administration of blood schizontocidal drug(s) against the acute attack and a hypnozoitocidal drug for the prevention of relapse due to latent hepatic stages of the parasite.1 There are many options for the former but just two for the latter: primaquine given daily for 7 or 14 days; or a single dose of tafenoquine. Currently the malaria control programme in India recommends 14 days of daily primaquine for radical cure of P. vivax.
No takes yet. Share an insight, caveat, or question.
J Kevin Baird (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: